Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) were down 0.7% during trading on Wednesday . The company traded as low as €19.49 ($20.52) and last traded at €19.89 ($20.94). Approximately 128,029 shares traded hands during mid-day trading, a decline of 75% from the average daily volume of 509,156 shares. The stock had previously closed at €20.04 ($21.09).
Analyst Upgrades and Downgrades
Separately, Citigroup decreased their price target on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating for the company in a research note on Wednesday, August 7th.
Read Our Latest Report on STVN
Stevanato Group Stock Down 0.2 %
Stevanato Group (NYSE:STVN – Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The business had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Stevanato Group’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.16 EPS. On average, sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.
Hedge Funds Weigh In On Stevanato Group
A number of large investors have recently made changes to their positions in the business. Hilltop National Bank increased its position in Stevanato Group by 34.3% during the 2nd quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock valued at $81,000 after buying an additional 1,122 shares in the last quarter. nVerses Capital LLC purchased a new stake in shares of Stevanato Group during the third quarter worth about $84,000. Harbor Capital Advisors Inc. increased its holdings in shares of Stevanato Group by 109.1% during the second quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock valued at $163,000 after acquiring an additional 4,626 shares in the last quarter. Raymond James Trust N.A. raised its position in shares of Stevanato Group by 18.7% in the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock valued at $188,000 after purchasing an additional 1,613 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its stake in Stevanato Group by 59.2% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock worth $219,000 after purchasing an additional 4,441 shares in the last quarter.
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Recommended Stories
- Five stocks we like better than Stevanato Group
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The Most Important Warren Buffett Stock for Investors: His Own
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a Low P/E Ratio and What Does it Tell Investors?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.